Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003826priorityCriticalpatent/ECSP003826A/en
Publication of ECSP003826ApublicationCriticalpatent/ECSP003826A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención describe compuestos de la fórmula I: y enantiómeros, diastereómeros y sales farmacéuticamente aceptables de los mismos. Los compuestos de la fórmula I son inhibidores de las proteína-cinasas y son útiles en el tratamiento de enfermedades proliferativas, por ejemplo, cáncer, inflamación y artritis. También pueden ser útiles en el tratamiento de la enfermedad de Alzheimer, alopecía inducida por quimioterapia y enfermedad cardiovascular.The present invention describes compounds of the formula I: and pharmaceutically acceptable enantiomers, diastereomers and salts thereof. The compounds of the formula I are inhibitors of protein kinases and are useful in the treatment of proliferative diseases, for example, cancer, inflammation and arthritis. They may also be useful in the treatment of Alzheimer's disease, chemotherapy-induced alopecia and cardiovascular disease.
ECSP0038262000-12-152000-12-15
INHIBITORS OF N- (5 (((5-ALQUIL-2-OXAZOLIL) METHYL) TIO) -2-TIAZOLIL) -CARBOXAMIDE OF CYCLINE-DEPENDENT KINASES
ECSP003826A
(en)